RG
LMAT icon

Renaissance Group’s LeMaitre Vascular LMAT Stock Holding History

Renaissance Group’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-15,462
Closed -$599K – 268
2018
Q3 		$599K Buy
15,462
+431
+3% +$15.5K 0.02% 199
2018
Q2 		$503K Buy
+15,031
New +$535K 0.02% 215

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
SCA
Summit Creek Advisors Minneapolis, Minnesota $294M AUM 19.1% 1-Year Est. Return

Renaissance Group's LMAT Position: Q4 2018 in Review

Renaissance Group sold out of LeMaitre Vascular (LMAT) in Q4 2018, closing a stake of 15,462 shares — an estimated $599K sold.

Renaissance Group first reported a position in LMAT in Q2 2018 and held it in 2 quarters. The position peaked at $599K in Q3 2018. 139 funds tracked by Wall St. Rank hold LMAT as of Q4 2018.

  • Renaissance Group reported no remaining LeMaitre Vascular position as of Q4 2018 after selling out during the quarter.
  • Renaissance Group sold 15,462 LeMaitre Vascular shares in Q4 2018, an estimated $599K.
  • Renaissance Group first reported a position in LeMaitre Vascular in Q2 2018 and held it in 2 quarters.
  • Renaissance Group's LeMaitre Vascular position peaked at $599K in Q3 2018.
  • 139 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2018.

Based on Renaissance Group's 13F filing for Q4 2018, filed 4 Feb 2019.